amgen

3 Biotech Stocks You’ll Regret Not Buying Soon

By Michael Que, InvestorPlace Contributor
The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200…

This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma

By InvestorPlace Research Staff
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.